Apex Biotechnology (Taiwan) Analysis
| 1733 Stock | TWD 28.50 0.15 0.53% |
Apex Biotechnology Corp is fairly valued with Real Value of 28.7 and Hype Value of 28.5. The main objective of Apex Biotechnology stock analysis is to determine its intrinsic value, which is an estimate of what Apex Biotechnology Corp is worth, separate from its market price. There are two main types of Apex Biotechnology's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Apex Biotechnology's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Apex Biotechnology's stock to identify patterns and trends that may indicate its future price movements.
The Apex Biotechnology stock is traded in Taiwan on Taiwan Stock Exchange, with the market opening at 09:00:00 and closing at 13:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Taiwan. Apex Biotechnology is usually not traded on National Day of the Republic of China. Apex Stock trading window is adjusted to Asia/Shanghai timezone.
Apex |
Apex Stock Analysis Notes
About 16.0% of the company shares are owned by insiders or employees . The company has Price-to-Book (P/B) ratio of 1.46. In the past many companies with similar price-to-book ratios have beat the market. Apex Biotechnology Corp last dividend was issued on the 16th of June 2022. The entity had 1:1 split on the 1st of July 2009. Apex Biotechnology Corp. engages in the research, development, manufacture, and sale of medical devices by using biosensor technology worldwide. Apex Biotechnology Corp. was founded in 1997 and is headquartered in Hsinchu, Taiwan. APEX BIOTECHNOLOGY operates under Biotechnology classification in Taiwan and is traded on Taiwan Stock Exchange. For more info on Apex Biotechnology Corp please contact Thomas Shen at 886 3 564 1952 or go to https://www.apexbio.com.Apex Biotechnology Corp Investment Alerts
| Apex Biotechnology generated a negative expected return over the last 90 days | |
| About 16.0% of the company shares are owned by insiders or employees |
Apex Biotechnology Thematic Classifications
In addition to having Apex Biotechnology stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | BiotechBiotechnology and pharmaceuticals production and services |
Apex Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.57 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Apex Biotechnology's market, we take the total number of its shares issued and multiply it by Apex Biotechnology's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Apex Profitablity
Apex Biotechnology's profitability indicators refer to fundamental financial ratios that showcase Apex Biotechnology's ability to generate income relative to its revenue or operating costs. If, let's say, Apex Biotechnology is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Apex Biotechnology's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Apex Biotechnology's profitability requires more research than a typical breakdown of Apex Biotechnology's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.1 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.08 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.08. Technical Drivers
As of the 24th of November, Apex Biotechnology shows the risk adjusted performance of (0.05), and Mean Deviation of 0.6774. Apex Biotechnology Corp technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Apex Biotechnology Corp coefficient of variation, variance, and the relationship between the mean deviation and standard deviation to decide if Apex Biotechnology Corp is priced correctly, providing market reflects its regular price of 28.5 per share.Apex Biotechnology Corp Price Movement Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Apex Biotechnology middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Apex Biotechnology Corp. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Apex Biotechnology Outstanding Bonds
Apex Biotechnology issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Apex Biotechnology Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Apex bonds can be classified according to their maturity, which is the date when Apex Biotechnology Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Apex Biotechnology Predictive Daily Indicators
Apex Biotechnology intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Apex Biotechnology stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Apex Biotechnology Forecast Models
Apex Biotechnology's time-series forecasting models are one of many Apex Biotechnology's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Apex Biotechnology's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Apex Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Apex Biotechnology prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Apex shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Apex Biotechnology. By using and applying Apex Stock analysis, traders can create a robust methodology for identifying Apex entry and exit points for their positions.
Apex Biotechnology Corp. engages in the research, development, manufacture, and sale of medical devices by using biosensor technology worldwide. Apex Biotechnology Corp. was founded in 1997 and is headquartered in Hsinchu, Taiwan. APEX BIOTECHNOLOGY operates under Biotechnology classification in Taiwan and is traded on Taiwan Stock Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Apex Biotechnology to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Share Portfolio Now
Share PortfolioTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Additional Tools for Apex Stock Analysis
When running Apex Biotechnology's price analysis, check to measure Apex Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apex Biotechnology is operating at the current time. Most of Apex Biotechnology's value examination focuses on studying past and present price action to predict the probability of Apex Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apex Biotechnology's price. Additionally, you may evaluate how the addition of Apex Biotechnology to your portfolios can decrease your overall portfolio volatility.